Black, Hispanic patients are neglected by 'one size fits all' MS trials. Genentech aims to change that FDA slaps partial hold on Avidity's lead program, docking dystrophy study over serious adverse event Months after an executive exodus, Exicure tells 66% of remaining staff to exit as it suspends all R&D work Genentech pays $70M to access Arsenal's armory of T-cell tools in quest for solid tumor CAR-T Sanofi pays Scribe $25M to access CRISPR tools, writing new chapter in its NK cell therapy story Biogen finalizes $900M deal to settle whistleblower’s long-running MS kickback suit MIT 'human radar' device tracks movement, gait speed of Parkinson's patients at home InterWell Health continues kidney care expansion with acquisition of Acumen Physician Solutions Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa HHS expands ownership data set for 15,000 Medicare-certified nursing homes MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda drugs | 